NCT07343089 A Multicenter Real-life Study of Disseminated Borreliosis Cases Occurring in Patients Receiving Anti-CD20 Treatment in France
| NCT ID | NCT07343089 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Strasbourg, France |
| Condition | Borrelia Infections |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-08-29 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-08-29 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Clinical, biological, radiological, and pharmacological description of cases of disseminated borreliosis (Borrelia burgdorferi sl. and Borrelia miyamotoi) occurring in patients who received drug treatment based on anti-CD20 monoclonal antibodies.
Eligibility Criteria
Inclusion Criteria: * Minor or adult subject * Having presented disseminated borreliosis confirmed by molecular biology (Borrelia burgdorferi sl. or Borrelia miyamotoi) within 24 months of receiving treatment with an anti-CD20 monoclonal antibody between January 1, 2010, and July 30, 2025. Exclusion Criteria: \- Refusal to participate in the study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07343089 clinical trial?
This trial is open to participants of all sexes, aged 1 Year or older, studying Borrelia Infections. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07343089 currently recruiting?
Yes, NCT07343089 is actively recruiting participants. Contact the research team at pierre.boyer@chru-strasbourg.fr for enrollment information.
Where is the NCT07343089 trial being conducted?
This trial is being conducted at Strasbourg, France.
Who is sponsoring the NCT07343089 clinical trial?
NCT07343089 is sponsored by University Hospital, Strasbourg, France. The trial plans to enroll 100 participants.